Glaucoma start-up gains $16m for implant trial
MELBOURNE: Glaucoma affects an estimated 70 million people worldwide and a Melbourne based biotech, PolyActiva,
MELBOURNE: Glaucoma affects an estimated 70 million people worldwide and a Melbourne based biotech, PolyActiva,
FEATURED
Best residential care home design for Global Awards shortlisted
Official trailer for ‘Boomers’ doc about the rise of the gerontocracy
Affordable housing lottery opens for seniors in new community
Best affordable seniors housing design for Global Awards shortlisted
‘Age tech’ can help bring dignity back to aged care
Best residential care home design for Global Awards shortlisted
INNOVATION
